Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

Katerina E. Paleologou, Christine L. Kragh, David M.A. Mann, Sultan A. Salem, Rania Al-Shami, David Allsop, Ahmed H. Hassan, Poul H. Jensen, Omar Ali El-Agnaf

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

A number of neurodegenerative diseases including Parkinsons disease, dementia with Lewy bodies (DLB) and multiple system atrophy are characterized by the formation and intraneuronal accumulation of fibrillar aggregates of α-synuclein (α-syn) protein in affected brain regions. These and other findings suggest that the accumulation of α-syn in the brain plays an important role in the pathogenesis of these diseases. However, more recently it has been reported that early amyloid aggregates or 'soluble oligomers' are the pathogenic species that lead to neurodegeneration and neuronal cell death rather than the later 'mature fibrils'. In this study, we investigated the presence of α-syn oligomers in brain lysates prepared from frozen post-mortem brains of normal, Alzheimers disease and DLB patients. The brain extracts were subjected to high speed centrifugation, to remove insoluble α-syn aggregates, followed by specific detection of soluble oligomers in the supernatants by employing FILA-1, an antibody that specifically binds to α-syn aggregates, but not to α-syn monomers, or to tau or β-amyloid aggregates. Using this novel enzyme-linked immunosorbent assay (ELISA) method to quantify the amounts of α-syn oligomers in the brain extracts, our data clearly show an increase in the levels of soluble oligomers of α-syn in the DLB brains compared to those with Alzheimers disease and the controls (P < 0.0001). Our findings provide strong evidence to support the contention that elevated soluble oligomers of α-syn are involved in the pathogenesis of DLB. Furthermore, these findings establish FILA-1 as a very sensitive tool for the detection of oligomeric forms of α-syn in human brain lysates.

Original languageEnglish
Pages (from-to)1093-1101
Number of pages9
JournalBrain
Volume132
Issue number4
DOIs
Publication statusPublished - Apr 2009
Externally publishedYes

Fingerprint

Synucleins
Lewy Body Disease
Brain
Alzheimer Disease
Amyloid
Multiple System Atrophy
Lewy Bodies
Oligomers
Dementia
Centrifugation
Neurodegenerative Diseases
Parkinson Disease
Cell Death
Enzyme-Linked Immunosorbent Assay

Keywords

  • α-synuclein
  • Amyloid oligomers
  • Dementia with Lewy bodies
  • Neurodegeneration

ASJC Scopus subject areas

  • Medicine(all)
  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. / Paleologou, Katerina E.; Kragh, Christine L.; Mann, David M.A.; Salem, Sultan A.; Al-Shami, Rania; Allsop, David; Hassan, Ahmed H.; Jensen, Poul H.; Ali El-Agnaf, Omar.

In: Brain, Vol. 132, No. 4, 04.2009, p. 1093-1101.

Research output: Contribution to journalArticle

Paleologou, KE, Kragh, CL, Mann, DMA, Salem, SA, Al-Shami, R, Allsop, D, Hassan, AH, Jensen, PH & Ali El-Agnaf, O 2009, 'Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies', Brain, vol. 132, no. 4, pp. 1093-1101. https://doi.org/10.1093/brain/awn349
Paleologou, Katerina E. ; Kragh, Christine L. ; Mann, David M.A. ; Salem, Sultan A. ; Al-Shami, Rania ; Allsop, David ; Hassan, Ahmed H. ; Jensen, Poul H. ; Ali El-Agnaf, Omar. / Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. In: Brain. 2009 ; Vol. 132, No. 4. pp. 1093-1101.
@article{c45fb6d470cf4d9d996fa89a9c81862b,
title = "Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies",
abstract = "A number of neurodegenerative diseases including Parkinsons disease, dementia with Lewy bodies (DLB) and multiple system atrophy are characterized by the formation and intraneuronal accumulation of fibrillar aggregates of α-synuclein (α-syn) protein in affected brain regions. These and other findings suggest that the accumulation of α-syn in the brain plays an important role in the pathogenesis of these diseases. However, more recently it has been reported that early amyloid aggregates or 'soluble oligomers' are the pathogenic species that lead to neurodegeneration and neuronal cell death rather than the later 'mature fibrils'. In this study, we investigated the presence of α-syn oligomers in brain lysates prepared from frozen post-mortem brains of normal, Alzheimers disease and DLB patients. The brain extracts were subjected to high speed centrifugation, to remove insoluble α-syn aggregates, followed by specific detection of soluble oligomers in the supernatants by employing FILA-1, an antibody that specifically binds to α-syn aggregates, but not to α-syn monomers, or to tau or β-amyloid aggregates. Using this novel enzyme-linked immunosorbent assay (ELISA) method to quantify the amounts of α-syn oligomers in the brain extracts, our data clearly show an increase in the levels of soluble oligomers of α-syn in the DLB brains compared to those with Alzheimers disease and the controls (P < 0.0001). Our findings provide strong evidence to support the contention that elevated soluble oligomers of α-syn are involved in the pathogenesis of DLB. Furthermore, these findings establish FILA-1 as a very sensitive tool for the detection of oligomeric forms of α-syn in human brain lysates.",
keywords = "α-synuclein, Amyloid oligomers, Dementia with Lewy bodies, Neurodegeneration",
author = "Paleologou, {Katerina E.} and Kragh, {Christine L.} and Mann, {David M.A.} and Salem, {Sultan A.} and Rania Al-Shami and David Allsop and Hassan, {Ahmed H.} and Jensen, {Poul H.} and {Ali El-Agnaf}, Omar",
year = "2009",
month = "4",
doi = "10.1093/brain/awn349",
language = "English",
volume = "132",
pages = "1093--1101",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies

AU - Paleologou, Katerina E.

AU - Kragh, Christine L.

AU - Mann, David M.A.

AU - Salem, Sultan A.

AU - Al-Shami, Rania

AU - Allsop, David

AU - Hassan, Ahmed H.

AU - Jensen, Poul H.

AU - Ali El-Agnaf, Omar

PY - 2009/4

Y1 - 2009/4

N2 - A number of neurodegenerative diseases including Parkinsons disease, dementia with Lewy bodies (DLB) and multiple system atrophy are characterized by the formation and intraneuronal accumulation of fibrillar aggregates of α-synuclein (α-syn) protein in affected brain regions. These and other findings suggest that the accumulation of α-syn in the brain plays an important role in the pathogenesis of these diseases. However, more recently it has been reported that early amyloid aggregates or 'soluble oligomers' are the pathogenic species that lead to neurodegeneration and neuronal cell death rather than the later 'mature fibrils'. In this study, we investigated the presence of α-syn oligomers in brain lysates prepared from frozen post-mortem brains of normal, Alzheimers disease and DLB patients. The brain extracts were subjected to high speed centrifugation, to remove insoluble α-syn aggregates, followed by specific detection of soluble oligomers in the supernatants by employing FILA-1, an antibody that specifically binds to α-syn aggregates, but not to α-syn monomers, or to tau or β-amyloid aggregates. Using this novel enzyme-linked immunosorbent assay (ELISA) method to quantify the amounts of α-syn oligomers in the brain extracts, our data clearly show an increase in the levels of soluble oligomers of α-syn in the DLB brains compared to those with Alzheimers disease and the controls (P < 0.0001). Our findings provide strong evidence to support the contention that elevated soluble oligomers of α-syn are involved in the pathogenesis of DLB. Furthermore, these findings establish FILA-1 as a very sensitive tool for the detection of oligomeric forms of α-syn in human brain lysates.

AB - A number of neurodegenerative diseases including Parkinsons disease, dementia with Lewy bodies (DLB) and multiple system atrophy are characterized by the formation and intraneuronal accumulation of fibrillar aggregates of α-synuclein (α-syn) protein in affected brain regions. These and other findings suggest that the accumulation of α-syn in the brain plays an important role in the pathogenesis of these diseases. However, more recently it has been reported that early amyloid aggregates or 'soluble oligomers' are the pathogenic species that lead to neurodegeneration and neuronal cell death rather than the later 'mature fibrils'. In this study, we investigated the presence of α-syn oligomers in brain lysates prepared from frozen post-mortem brains of normal, Alzheimers disease and DLB patients. The brain extracts were subjected to high speed centrifugation, to remove insoluble α-syn aggregates, followed by specific detection of soluble oligomers in the supernatants by employing FILA-1, an antibody that specifically binds to α-syn aggregates, but not to α-syn monomers, or to tau or β-amyloid aggregates. Using this novel enzyme-linked immunosorbent assay (ELISA) method to quantify the amounts of α-syn oligomers in the brain extracts, our data clearly show an increase in the levels of soluble oligomers of α-syn in the DLB brains compared to those with Alzheimers disease and the controls (P < 0.0001). Our findings provide strong evidence to support the contention that elevated soluble oligomers of α-syn are involved in the pathogenesis of DLB. Furthermore, these findings establish FILA-1 as a very sensitive tool for the detection of oligomeric forms of α-syn in human brain lysates.

KW - α-synuclein

KW - Amyloid oligomers

KW - Dementia with Lewy bodies

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=65249162241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249162241&partnerID=8YFLogxK

U2 - 10.1093/brain/awn349

DO - 10.1093/brain/awn349

M3 - Article

C2 - 19155272

AN - SCOPUS:65249162241

VL - 132

SP - 1093

EP - 1101

JO - Brain

JF - Brain

SN - 0006-8950

IS - 4

ER -